Shukra Pharma.

51
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE551C01044
  • NSEID:
  • BSEID: 524632
INR
39.73
-0.78 (-1.93%)
BSENSE

Feb 01

BSE+NSE Vol: 2.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -56.30% vs 26.75% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -34.39% vs 261.78% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 108.74% vs 1.50% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -48.35% vs 320.68% in Mar 2024

Compare Profit and Loss Results of Shukra Pharma.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
32.00
759.00
-727.00
-95.78%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
32.00
759.00
-727.00
-95.78%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-21.00
18.00
85.71%
Raw Materials Consumed
11.00
493.00
-482.00
-97.77%
Power & Fuel Cost
0.00
21.00
-21.00
-100.00%
Employee Cost
6.00
122.00
-116.00
-95.08%
Operating Expenses
0.00
11.00
-11.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
12.00
-12.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
4.00
-4.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
665.00
-646.00
-97.14%
Operating Profit (PBDIT) excl Other Income
12.00
94.00
-82.00
-87.23%
Other Income
4.00
17.00
-13.00
-76.47%
Operating Profit (PBDIT)
16.00
111.00
-95.00
-85.59%
Interest
0.00
4.00
-4.00
-100.00%
Profit before Depriciation and Tax
16.00
107.00
-91.00
-85.05%
Depreciation
3.00
27.00
-24.00
-88.89%
Profit Before Taxation & Exceptional Items
13.00
79.00
-66.00
-83.54%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
79.00
-66.00
-83.54%
Provision for Tax
3.00
18.00
-15.00
-83.33%
Profit After Tax
9.00
60.00
-51.00
-85.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
37.00
226.00
-189.00
-83.63%
Profit Available for appropriations
47.00
286.00
-239.00
-83.57%
Appropriations
47.00
286.00
-239.00
-83.57%
Equity Dividend (%)
1%
116%
-115.00
Earnings Per Share
0.22
29.03
-28.81
-99.24%
Profit And Loss - Net Sales
Net Sales 32.59 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -56.30% vs 26.75% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -34.39% vs 261.78% in Mar 2024

Profit And Loss - Interest
Interest 0.59 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 108.74% vs 1.50% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 9.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -48.35% vs 320.68% in Mar 2024